| You are in:Home/Publications/Comparative Study of the Efficacy of Combined Sofosbuvir Ribavirin in Treatment Naive versus Treatment Experienced Egyptian Patients with Chronic Hepatitis C | |
Dr. Ayman mohammed Ibrahim Afifi Esmail El badway :: Publications: |
|
| Title: | Comparative Study of the Efficacy of Combined Sofosbuvir Ribavirin in Treatment Naive versus
Treatment Experienced Egyptian Patients with Chronic Hepatitis C |
| Authors: | Ayman El-Badawy1, Mohamed YehiaSeddek1, Mohamed Shawky El-sayed1 and Azez Mohammed Bedeer2. |
| Year: | 2016 |
| Keywords: | Not Available |
| Journal: | International Journal of Advanced Research |
| Volume: | 4 |
| Issue: | 11 |
| Pages: | 1081-1087 |
| Publisher: | Not Available |
| Local/International: | International |
| Paper Link: | Not Available |
| Full paper | Ayman mohammed Ibrahim Afifi Esmail El badway_05 azez final.pdf |
| Supplementary materials | Not Available |
| Abstract: |
We conducted this study to assess the efficacy of the oral nucleotide polymerase inhibitor sofosbuvir in combination with ribavirin in Egyptian patients chronically infected with genotype 4 hepatitis C virus (HCV). Methods: Treatment-naive and previously treated patients withgenotype 4 HCV were randomly allocated in a 1:1 ratio to receive sofosbuvir 400 mg and weight-based ribavirin , for 24 weeks. The primary efficacy endpoint was the proportion of patients with sustained virologic response (HCV RNA |
